Brought to you by 
Thoratec sells International Technidyne for $55mm in cash
04 Nov 2022
Executive Summary
Thoratec Corp. (advanced-stage heart failure devices) has sold International Technidyne Corp. (ITC; hemostasis management and point-of-care (POC) testing products) to an affiliate of Warburg Pincus for $55mm in cash.
Deal Industry
- In Vitro Diagnostics
- Medical Devices
-
In Vitro Diagnostics
- Hematology, Coagulation
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash for Equity
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Thoratec sells International Technidyne for $55mm in cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice